I-lymphocytic leukemia, okanye i-CLL , i- leukemia eqhelekileyo kubantu abadala eMelika.
Kuthiwani nge-leukemia ekhuselekileyo, okanye i-AML?
- Ukuba usenza uphando olukhawulezayo lwewebhu, oku kungakhokelela ekubeni ukholelwe ukuba i-AML yiyona leyemia eqhelekileyo kubantu abadala. I-AML inenani elipheleleyo le-diagnosti ngamnye kunyaka, nangona ke inani elipheleleyo libonisa umnikelo omkhulu kubantwana-i-AML yi- leyemia yesibini exhaphakileyo kubantwana, kwaye i-leukemia ngumdla wesiqhelo obuninzi kubantwana .
- I-AML yimiba ye - leyemia eqhelekileyo kubantu abadala, enokuba yinto enye yokudideka. Ngokubhekisele kwi-leukemia, amagama anzima kwaye angapheliyo anentsingiselo eyahlukileyo kunokuba ayenzayo, yathetha, xa uthetha nge-bronchitis ekhangelelana ne-bronchitis engapheliyo. I-leukemia echaphazelekayo ibhekisela ekuthambekeni kokuqhubela phambili ngokukhawuleza, ngelixa isifo esingapheli sibhekisela kwi-leukemia eyayibonwa njengembali yokukhula esicothayo umntu angaphila nayo iminyaka. Namhlanje, i-leukemia engapheliyo yaziwa ngokungafaniyo, kunye namaxesha okuphila aphuma kwiminyaka engama-2 ukuya kwe-20 ukusuka ngexesha lokuxilongwa.
Phakathi kwabantu abadala, iindidi eziqhelekileyo ze-leukemia zi-CLL (iipesenti ezingama-37) kunye ne-AML (iipesenti ezingama-31). ZONKE ziqhelekileyo kule minyaka eyi-0 ukuya kwe-19, zibalwa ngamaphesenti angama-75 kwiimeko kuloo qela.
Uqikelelo lwe-2016-2017
Abantu abangama-62,130 (bonke ubudala) baya kufumaniswa ukuba bane-leukemia, ngokwe-American Cancer Society.
Nantsi ukuphazamiseka ngohlobo (yonke iminyaka):
I-Acute Myeloid Leukemia: 21,380
I-Lymphocytic Leukemia: 20,110
I-Leukemia ye-Myeloid engapheliyo: 6,660
I-Acute Lymphocytic Leukemia: 5,970
Ezinye i-Leukemia: 5,910
I-CLL Iinkcukacha kunye namanani
I-CLL ithathwa njengesibonakaliso esahlukileyo sesifo esifana ne-lymphocytic lymphoma, okanye i-SLL-enye ye-lymphomas ekhula ngokukhawuleza engekho iHodgkin.
Imbali yentsapho iyafaneleka kwi-CLL; Abazali, abantakwabo, okanye abantwana babantu abaxilongwa nge-CLL banomngcipheko ophindwe kabini wokuzihlakulela ngokwabo.
Nazi ezinye iinkcukacha ezongezelelweyo ezivela kwi-American Cancer Society:
- Phantse iipesenti ezingama-25 zazo zonke iimeko ezintsha ze-leukemia zi-CLL
- Umyinge wengozi yobomi bokufumana i-CLL i malunga no-1 ngo-200
- Umngcipheko we-CLL uphakamileyo kakhulu kumadoda kunabesifazane
- Umyinge weminyaka ubudala ukuxilongwa malunga neminyaka engama-71
- I-CLL ayinqabile phantsi kweminyaka engama-40, kwaye inqabile kakhulu kubantwana.
Izikhokelo malunga neCause
Ngokwe-American Cancer Society, abaphandi bakholelwa ukuba i-CLL iqala xa i- B-lymphocyte-uhlobo lwegazi elimhlophe elingakhula ukwenza i-antibodies - liqhubeke ukuhlukana kwaye lingaxinwa emva kokuhlangana nokuqaphela i-antigen yangaphandle . Iinkcukacha malunga nendlela oku kwenzeka ngayo kunye neenkcukacha zazo zonke iimanyathelo ezibandakanyekayo azikaziwa, kodwa ezinye zezinto zokuzalwa ze-CLL ziye zachazwa kwaye ziyaqala ukuqondwa kangcono.
Malunga ne-17p yokuCima i-CLL
I-CLP yokucima i-17p yabizwa ngokuba iqela le-chromosome ethile, i-chromosome 17, ilahlekile-kwaye, ininzi yexesha, kunye nayo iya kuba nomzimba obalulekileyo obizwa ngokuba yi-p53 olawula i-apoptosis, okanye ukufa kweseli ehleliweyo.
Ukususwa kwe-17p kufumaneka kwi-3 ukuya kwi-10 ekhulwini labantu abane-CLL, ngokubanzi. Ukukhishwa kwe-CLP ye-17p yindlela ye-CLL enzima ukuyiphatha; Abantu abane-CLP yokususa i-CLL banzima ukunyanga kunye ne-chemotherapy eqhelekileyo. Ixabiso eliphakathi, okanye eliphakathi, lokulindela ubomi liphantsi kweminyaka emithathu.
Ukufumana okungakumbi kulo, funda icandelo 'CLL kunye no-17p ukususwa' kwinqaku edibeneyo.
Ukufumana ulwazi olubanzi malunga ne-CLL, jonga inqaku likaKaren Raymaakers .
> Imithombo:
> I-Leukemia neLymphoma Society. Iinkcukacha kunye nezibalo. Kufike ngoSeptemba 2017.
> I-American Cancer Society. I-Leukemia - Lymphocytic engapheliyo. Kufike ngoSeptemba 2017.
> ICcercer Facts & Figures, 2017 . American Cancer Society. 2017. Kufumaneka ngoSeptemba 2017.